Bacillus subtilis BSP110™

Bacillus subtilis BSP110™

Products
Bacillus subtilis BSP110™
Bacillus subtilis BSP110™

Information

Bacillus subtilis BSP110™ is a stable, spore-forming probiotic that supports gut health and microbial balance. Preclinical evaluation, as reported in the research article for BSP110™, confirms a strong safety profile. In vitro studies show that the strain is non-cytotoxic, while in vivo studies demonstrate no toxicity or adverse effects, with a high safety margin (NOAEL established). Findings indicate that BSP110™ is safe, well-tolerated, and suitable for probiotic applications in nutraceutical and pharmaceutical formulations.
Health & Wellness Areas
Digestive HealthImmune Support
Ingredients
Microorganisms & Probiotics
Certifications
Allergen-freeGluten-freeHalalHealth & Safety (GMP, HACCP and Equivalents)KosherNon-GMOVeganOther Certifications
Pellucid lifesciences pvt ltd3K244Pellucid Lifesciences Private Limited is a fermentation-based biotechnology company founded in 2013 and located in Chhatral, Gujarat, India. Established with a vision to become a global leader in the manufacturing and marketing of probiotics, Pellucid focuses on spore-forming probiotics and delivers clinically backed, shelf-stable solutions that overcome traditional limitations of viability and scalability. With proprietary strains like BCP92™ and strong expertise in spray drying and formulation, the company enables brands to create differentiated, high-efficacy products across gut health, immunity, and beyond. The company operates a state-of-the-art fermentation facility with an R&D centre, established in 2016, supported by an experienced team specializing in microbiology, process development, and quality management. Pellucid offers a comprehensive portfolio of high-quality probiotic strains for a wide range of applications, including dietary supplements, nutraceuticals, and food and beverage formulations. Key strains include: Bacillus coagulans BCP92™ – Clinically proven and approved as GRAS (Generally Recognized as Safe) by the USFDA Bacillus clausii PBC429™- Clinically safe Bacillus subtilis BSP110™- Clinically safe These strains, along with others in Pellucid’s portfolio, offer high efficacy, stability, and versatility across various product formats. In addition to supplying individual strains and customized blends, Pellucid provides finished dosage forms including capsules, tablets, sachets, and gummies, along with contract manufacturing and white-label solutions for scalable global production. Quality and compliance are at the core of Pellucid’s operations. The company adheres to stringent international standards and holds multiple certifications, including. cGMP HACCP FSSAI FSSC 22000 v5 ISO 22000:2005 ISO/TS 22002-1:2009 HALAL Kosher (Star-K) Health Canada (NPN Approved)- Product License for Bacillus coagulans Driven by strong scientific research and customer-centric innovation, Pellucid Lifesciences continues to advance the probiotic industry by delivering world-class solutions tailored to evolving market needs, paving the way for sustainable growth and a healthier future.

Join the event!

See all the content and easy-to-use features by logging in or registering!